Valuation: MRI Interventions Inc

Market Cap 41Cr 35Cr 33Cr 30Cr 57Cr 3.92TCr 57Cr 399.69Cr 154.44Cr 1.99TCr 153.55Cr 150.14Cr 6.34TCr P/E 2026 *
-10.3x
P/E 2027 * -11.2x
Enterprise Value 41Cr 35Cr 33Cr 30Cr 57Cr 3.92TCr 57Cr 399.69Cr 154.44Cr 1.99TCr 153.55Cr 150.14Cr 6.34TCr EV / Sales 2026 *
8.34x
EV / Sales 2027 * 7.23x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
+24.88%-8.05% - - 41Cr
+0.27%+7.06%+34.88%+25.78% 24TCr
-0.65%+1.71%+9.39%-18.37% 15TCr
+0.21%+8.22%-12.02%+29.35% 14TCr
-0.75%-2.34%-55.64%-16.99% 6.36TCr
+0.08%+0.03%-18.68%-15.11% 4.93TCr
-0.39%+3.60%+18.90%+21.97% 5.15TCr
+0.25%+6.18%+20.83%+32.59% 4.33TCr
+0.63%+3.42%+38.13%+51.79% 4.11TCr
+2.66%+11.67%+125.59%+56.64% 3.46TCr
Average +2.73%+3.16%+17.93%+18.63% 8.94TCr
Weighted average by Cap. +0.12%+4.32%+14.22%+15.23%

Financials

2026 *2027 *
Net sales 4.9Cr 4.25Cr 4.01Cr 3.64Cr 6.83Cr 470.07Cr 6.87Cr 48Cr 19Cr 238.42Cr 18Cr 18Cr 759.96Cr 5.66Cr 4.9Cr 4.63Cr 4.21Cr 7.88Cr 542.5Cr 7.93Cr 55Cr 21Cr 275.16Cr 21Cr 21Cr 877.06Cr
Net income -3.96Cr -3.43Cr -3.24Cr -2.94Cr -5.51Cr -379.41Cr -5.54Cr -39Cr -15Cr -192.44Cr -15Cr -15Cr -613.4Cr -3.88Cr -3.36Cr -3.17Cr -2.88Cr -5.4Cr -371.74Cr -5.43Cr -38Cr -15Cr -188.55Cr -15Cr -14Cr -600.99Cr
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!